CRY2 and metastatic malignant neoplasm in the lymph nodes: The pooled ORs were 1.35 (95%CI: 0.84∼2.15, Ρ=0.214) forCry2 and differentiation, 0.85 (95%CI: 0.44∼1.66, Ρ=0.636) for Cry2 and invasion depth and 1.10 (95%CI: 0.80∼1.52, Ρ=0.543) for Cry2 and lymph node metastasis.